Activating PIK3CA mutations are exceedingly uncommon among pediatric cancers (< 1 % of leukemias and solid tumors and < 3 % of brain tumors), and the PPTC panel of approximately 240 models has none with activating PIK3CA mutations (St. This evidence concerns the gene PIK3CA and brain neoplasm.